Ashkan Mortezavi

1.5k total citations
64 papers, 1.1k citations indexed

About

Ashkan Mortezavi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Ashkan Mortezavi has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 13 papers in Rheumatology. Recurrent topics in Ashkan Mortezavi's work include Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (32 papers) and Urologic and reproductive health conditions (12 papers). Ashkan Mortezavi is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (36 papers), Prostate Cancer Treatment and Research (32 papers) and Urologic and reproductive health conditions (12 papers). Ashkan Mortezavi collaborates with scholars based in Switzerland, Sweden and Germany. Ashkan Mortezavi's co-authors include Daniel Eberli, Tullio Sulser, Thomas Hermanns, Holger Moch, Olivio F. Donati, Niels J. Rupp, Peter J. Wild, Benedikt Kranzbühler, Glen Kristiansen and Hans‐Helge Seifert and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Ashkan Mortezavi

57 papers receiving 1.1k citations

Peers

Countries citing papers authored by Ashkan Mortezavi

Since Specialization

Citations

This map shows the geographic impact of Ashkan Mortezavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashkan Mortezavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashkan Mortezavi more than expected).

Fields of papers citing papers by Ashkan Mortezavi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashkan Mortezavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashkan Mortezavi. The network helps show where Ashkan Mortezavi may publish in the future.

Co-authorship network of co-authors of Ashkan Mortezavi

This figure shows the co-authorship network connecting the top 25 collaborators of Ashkan Mortezavi. A scholar is included among the top collaborators of Ashkan Mortezavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashkan Mortezavi. Ashkan Mortezavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Influence of Regular Statin Intake on Prostate‐Specific Antigen Values, Prostate Cancer Incidence and Overall Survival in a Prospective Screening Trial ( ERSPC Aarau) 2025 ·Cancer Medicine ·(unknown), Maciej Kwiatkowski, Stephen Wyler, Ashkan Mortezavi, Lukas Manka, Marian S. Wettstein, Rainer Grobholz, Angelika Hammerer‐Lercher, Daniel Eberli, (unknown)	0
2	Cost Analysis of Prostate Cancer Care Using a Biomarker-enhanced Diagnostic Strategy with Stockholm3 2024 ·European Urology Open Science ·(unknown), (unknown), Jochen Walz, Derya Tilki, Alberto Briganti, Armando Stabile, (unknown), Ashkan Mortezavi, (unknown), Tim Dudderidge, Tim M. Govers, Henrik Grönberg, Hari T. Vigneswaran	0
3	Prospective Multicenter Validation of the Stockholm3 Test in a Central European Cohort 2023 ·European Urology Focus ·(unknown), Karim Saba, August Sigle, Christian Wetterauer, (unknown), (unknown), (unknown), Patrick Maurer, (unknown), Richard Cathomas, Räto T. Strebel, Christian Gratzke, (unknown), Cyrill A. Rentsch, Ashkan Mortezavi	6
4	Focal therapy with high‐intensity focused ultrasound for prostate cancer: 3‐year outcomes from a prospective trial 2023 ·British Journal of Urology ·(unknown), (unknown), Florian Schmid, (unknown), (unknown), (unknown), Olivio F. Donati, Niels J. Rupp, Holger Moch, Michael A. Gorin, Ashkan Mortezavi, Daniel Eberli	13
5	Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study 2023 ·Swiss Medical Weekly ·(unknown), Karim Saba, Marian S. Wettstein, Ilaria Lucca, Ashkan Mortezavi, (unknown), Drahomir Aujesky, (unknown), Raeto T. Strebel	1
6	External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort 2022 ·European Urology Open Science ·(unknown), (unknown), Donna P. Ankerst, Sebastiaan Remmers, Ashkan Mortezavi, (unknown), Lars Egevad, Henrik Grönberg, Martin Eklund, Tobias Nordström	7
7	Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate Cancer 2022 ·European Urology Focus ·Bram De Laere, Alessio Crippa, Andrea Discacciati, (unknown), Jan Oldenburg, Ashkan Mortezavi, Piet Ost, Martin Eklund, Johan Lindberg, Henrik Grönberg	8
8	Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Daniela A. Ferraro, Anton S. Becker, Benedikt Kranzbühler, (unknown), (unknown), Konstantinos Zeimpekis, Hannes Grünig, Michael Messerli, Niels J. Rupp, Jan H. Rueschoff, Ashkan Mortezavi, Olivio F. Donati, Marcelo Tatit Sapienza, Daniel Eberli, Irene A. Burger	59
9	Morbidity and mortality after robot‐assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group 2020 ·British Journal of Urology ·Ashkan Mortezavi, Alessio Crippa, (unknown), Saša Pokupić, Paolo Dell’Oglio, Francesco Montorsi, Frederiek DʼHondt, Alexandre Mottrie, Karel Decaestecker, Carl Wijburg, Justin Collins, John D. Kelly, Wei Shen Tan, Ashwin Sridhar, Hubert John, Abdullah Erdem Canda, Christian Schwentner, Erik Rönmark, Peter Wiklund, Abolfazl Hosseini	14
10	Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies 2020 ·World Journal of Urology ·Anna Lantz, Erik Skaaheim Haug, Wolfgang Picker, Alessio Crippa, Fredrik Jäderling, Ashkan Mortezavi, Tobias Nordström	2
11	Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cells 2020 ·Urologic Oncology Seminars and Original Investigations ·Daniel Eberli, Benedikt Kranzbühler, Ashkan Mortezavi, Tullio Sulser, Souzan Salemi	15
12	Combined N‐terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cells 2018 ·The Prostate ·Benedikt Kranzbühler, Souzan Salemi, Ashkan Mortezavi, Tullio Sulser, Daniel Eberli	15
13	Diagnostic accuracy of mpMRI and fusion-guided targeted biopsy evaluated by transperineal template saturation prostate biopsy for the detection and characterization of prostate cancer 2018 ·The Journal of Urology ·Ashkan Mortezavi, (unknown), Olivio F. Donati, (unknown), Niels J. Rupp, Marian S. Wettstein, Oliver Groß, Tullio Sulser, Thomas Hermanns, Daniel Eberli	17
14	A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients 2017 ·Scientific Data ·Qing Zhong, Tiannan Guo, Markus Rechsteiner, Jan H. Rüschoff, Niels J. Rupp, Christian D. Fankhauser, Karim Saba, Ashkan Mortezavi, Cédric Poyet, Thomas Hermanns, Yi Zhu, Holger Moch, Ruedi Aebersold, Peter J. Wild	18
15	Extraction Strings for Ureteric Stents: Is There an Increased Risk for Urinary Tract Infections? 2017 ·Surgical Infections ·(unknown), Jan Fehr, Tullio Sulser, Daniel Eberli, Ashkan Mortezavi	18
16	Acute Abdominal Pain Accompanied by High Creatinine in a Female Patient With Schizophrenia 2014 ·Urology ·(unknown), Martin Lüscher, Cédric Poyet, Karim Saba, Gustav Andreisek, Tullio Sulser, Ashkan Mortezavi	4
17	Continuous Low-Dose Aspirin Therapy in Robotic-Assisted Laparoscopic Radical Prostatectomy Does Not Increase Risk of Surgical Hemorrhage 2013 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Ashkan Mortezavi, Thomas Hermanns, Lukas J. Hefermehl, Donat R. Spahn, Burkhardt Seifert, (unknown), (unknown), Daniel M. Schmid, Tullio Sulser, Daniel Eberli	9
18	KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy 2011 ·Clinical Cancer Research ·Ashkan Mortezavi, Thomas Hermanns, Hans‐Helge Seifert, Martin Baumgartner, Maurizio Provenzano, Tullio Sulser, Maximilian Burger, M. Montani, Kristian Ikenberg, Ferdinand Hofstädter, Arndt Hartmann, Rolf Jaggi, Holger Moch, Glen Kristiansen, Peter J. Wild	84
19	MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer 2011 ·PLoS ONE ·Lotta von Boehmer, (unknown), Ashkan Mortezavi, Maurizio Provenzano, (unknown), Thomas Hermanns, Tullio Sulser, Achim A. Jungbluth, Lloyd J. Old, Glen Kristiansen, Maries van den Broek, Holger Moch, Alexander Knuth, Peter J. Wild	46
20	Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy 2009 ·Clinical Cancer Research ·Karina D. Sørensen, Peter J. Wild, Ashkan Mortezavi, (unknown), Niels Tørring, Sara Heebøll, Benedicte Parm Ulhøi, Peter D. Ottosen, Tullio Sulser, Thomas Hermanns, Holger Moch, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact